HISTOPATHOLOGY INDIA.COM

              Adult Respiratory Distress Syndrome

  DESIGNED  AND  MAINTAINED 
 BY   DR  SAMPURNA  ROY   MD     

Custom Search

 

 

Paediatric Renal Tumours

Mesoblastic Nephroma

Wilms’ tumour (nephroblastoma)

Wilms' tumour related lesions

Nephrogenic rests

Clear Cell Sarcoma of the Kidney

Malignant Rhabdoid Tumour of Kidney

Diagnosis of Paediatric tumours

Neuroblastoma

Ewing's sarcoma / PNET

Desmoplastic Small Round Cell Tumour

Rhabdomyosarcoma

Hepatoblastoma

Retinoblastoma

Lipoblastoma

Cellular Hemangioma of Infancy

Acquired tufted angioma

Kaposiform hemangioendothelioma

Fibrous Hamartoma of Infancy

Infantile Myofibromatosis

(Desmoid-type) Fibromatosis

Fibromatosis colli

Juvenile Hyaline Fibromatosis

Inclusion Body Fibromatosis

Calcifying Aponeurotic Fibroma

Lipofibromatosis

Congenital and Infantile Fibrosarcoma

Giant Cell Fibroblastoma

Rhabdomyomatous Mesenchymal Hamartoma

Fetal Rhabdomyoma

Cervical Thymic Cyst

Yolk Sac Tumour

Hirschsprung's Disease

Neonatal Necrotizing Enterocolitis

Gaucher's Disease

Congenital Heart Disease

Paediatric Tumours of Eye and Orbit

Paediatric Head and Neck Pathology

Paediatric Scalp and Skull lesions

Paediatric Cystic Lesions

Paediatric Nasal Lesions

Juvenile Nasopharygeal Angiofibroma

Salivary gland anlage tumour of the nasopharynx

Heterotopic Glial Nodule

Paediatric Thyroid Disorders

Paediatric Salivary Gland Lesions

Paediatric Intra-Oral Tumours

Congenital Epulis

Cervical Lymphadenopathy

Juvenile papillomatosis

Cervical Thymic Cyst

Paediatric Head and Neck Neoplasm

Neuroblastoma

Ewing's sarcoma / PNET

Fetal Rhabdomyoma

Rhabdomyosarcoma

Langerhans cell histiocytosis (Histiocytosis X)

Paediatric Pancreatic Tumours

Pancreatoblastoma

Developmental Defects of Pancreas

Nesidioblastosis

Pancreas Divisum

Aberrant (Ectopic) or Accessory Pancreas

Annular Pancreas

Pancreatic Agenesis

Congenital Cystic Adenomatoid Malformation

Bronchopulmonary Sequestration

Neonatal Respiratory Distress Syndrome

Complications of Neonatal Respiratory Distress Syndrome

Langerhans cell histiocytosis (Histiocytosis X)

Protein Calorie Malnutrition

Marasmus

Kwashiorkor

Melanocytic tumours  

Acquired Melanocytic Naevus  ; Mongolian Spots /Ota's naevus /Ito's naevus   Congenital naevus ; Spitz naevus Spindle cell naevus ; Ancient Naevus  ;  Halo naevus  ;  Balloon cell naevus Blue naevus-variants ; Deep penetrating naevus   ; Combined Naevus ; Recurrent naevus ; Dysplastic naevus .

 Solid tumors in children. New advances and the importance of histological sub-classifications. I. Renal tumors in children.Ann Pathol. 1988;8(2):114-25.

New information is now provided to the pediatric pathologist through the application of new techniques as immunocytochemistry, cytogenetics, flow cytometry, etc... Their confrontation with better analysis of histopathology and extremely valuable data provided through Electron Microscopy and tissue culture has led to important progress in sub-classification of tumors, and especially definition of histologic patterns correlating with favorable or unfavorable response to therapy. This is especially true in the field of renal tumors. Clear cell sarcoma of the kidney (CCSK) and malignant rhabdoid tumors (MRTK) have recently been isolated as tumors of unfavorable prognosis. The actuarial 2-year survival rate is 49% for CCSK and 10% for MRTK (versus 95% for Wilms' Tumor). Amongst tumors of good prognosis are congenital mesoblastic nephroma which can be considered as a benign tumor, when no atypia is present, and cystic partially differentiated nephroblastoma, which is potentially malignant but in most cases is related to favorable outcome. Attention should be now focused on minimising the sequela of treatment, which requires different strategies according to extension of disease and histologic subclassification.

Solid tumors in the child. New advances and the importance of histological sub-classifications. II. Tumors of the peripheral nervous system, soft tissue, liver and pancreas.Ann Pathol. 1988;8(2):126-35.

According to immunohistochemical, ultrastructural features of neural cells, and identical 11; 22 chromosome translocation, at least some extra osseous Ewing's sarcoma, as well as the malignant small cell tumor of the thoracopulmonary region (Askin's tumor) are actually classified as peripheral neuroepitheliomas. Embryonal rhabdomyosarcoma, including the botryoid variant, is now, when treated with appropriate chemotherapy, a tumor of relatively favorable histology. Its prognosis is still primarily related to clinical stage and location of tumor. The alveolar subtype of rhabdomyosarcoma (including its solid variant) has a less favorable prognosis. Hepatoblastoma (epithelial or mixt variants) have the same long term survival, also mainly related to stage. Pancreatoblastoma is a tumor with well differentiated cytopathology and prolonged course, compared with other pancreatic tumors.

Custom Search


 

 

 

 

 CLICK ON THE IMAGES

June 2009

Histopathology-India.net

diagnostichistopathology. blogspot.com

Pathopedia-India.com

Surgical-Pathology.com

Pathology-India.com

Pancreatic Pathology Online

Gall Bladder Pathology Online

Paediatric Pathology Online

Paraganglioma-Online

Endocrine Pathology Online

Eye Pathology Online

Ear Pathology Online

Cardiac Path Online

Lung Tumour-Online

Mesothelioma-Online

Pulmonary Pathology Online

Nutritional Pathology Online

Environmental Pathology Online

Pathology Quiz Online

Dermpath-India

GI Path Online

Soft Tissue Pathology

Case Index

Infectious Disease Online; INDEX: A-D ; INDEX: E-L ; INDEX: M-P INDEX: Q-Z ; FUNGAL DISEASE ; VIRAL DISEASE.

E-book - History of  Medicine with special reference to India.

Basic Pathology Blog

 Retrospective study on amplification of N-myc and c-myc genes in pediatric solid tumors and its association with prognosis and tumor differentiation.
Lab Invest. 1988 Sep;59(3):321-7.

DNA was extracted from formalin-fixed and paraffin-embedded tissues of 85 patients with pediatric malignant solid tumors which had been resected at surgery or obtained at autopsy during a 24-year period. The tumors examined included 25 rhabdomyosarcomas, 12 Wilms' tumors, 10 hepatoblastomas and 37 neuroblastoma group tumors. Neuroblastoma group tumors were subclassified into 25 neuroblastomas and 12 ganglio neuroblastomas among which 6 composite ganglio neuroblastomas were included. Sample blocks were selected from both tumors and normal tissues in the majority of cases. We were able to reliably detect N- and c-myc gene amplification in tumor DNA by dot blot-hybridization. The N-myc gene showed approximately from 3- to 500-fold amplification in 19 of 33 cases of stage IV neuroblastoma group tumor. All of these 33 patients had been intensively treated with chemotherapy and/or radiotherapy. The c-myc was amplified 8-fold in 1 case of rhabdo myosarcoma, but neither N-myc nor c-myc was amplified in any cases of Wilms' tumor or hepatoblastoma. We retrospectively examined the association among N-myc gene amplification, prognosis, and histologic subtype in 33 patients with stage IV neuroblastoma group tumors. The survival of the patients with N-myc gene amplification was shorter than that of the patients without amplification of N-myc (p less than 0.05). There was no significant difference in prognosis between the 2 histologic subtypes; neuroblastoma and ganglioneuroblastoma, and the cases of tumors with amplified N-myc showed shorter survivals for each subtype (p less than 0.05). In every case of neuroblastoma group tumor, the copy number of the N-myc gene was the same among primary site and multiple metastatic tumors, even when the lesions showed differences in histologic subtype like neuroblastoma and ganglioneuroblastoma.

Role of prognostic factors in the management of pediatric solid tumors.Ann N Y Acad Sci. 2008 Sep;1138:32-42.

The importance of prognostic factors in predicting outcome in pediatric oncology is largely recognized, and most current protocols tailor treatment based on risk stratification. Further refinements of classical staging systems are ongoing, and the future of pediatric oncology is in the development of strategies based on individual tumor characteristics. This review details significant advances in our understanding of prognostic factors in the most common pediatric solid tumors and potential applications for clinical management.

 

 

 

 

 

 

 

 

 
 

 

 

 


 

 

 

 

 

 

 

 

 

 

 

 


 Disclaimer  ;  Privacy Policy  ; Advertising Policy  ;  E-mail 

Copyright © 2009 surgical-pathology.com
    All rights reserved